Both in Pharmaceuticals
PMGC Holdings vs Sunshine Biopharma
Over the past year ELAB returned −99.7% and SBFM returned −94.6%; their daily moves had a correlation of -0.01.
ELAB −99.7% SBFM −94.6%Growth of $1, one year, split-adjusted
| Metric | ELAB | SBFM |
|---|---|---|
| Price | $3.67 | $0.7874 |
| Market cap | $3.0M | $3.1M |
| Today | −23.22% | −3.73% |
| 1 month | −30.9% | −31.5% |
| 6 months | −89.7% | −92.2% |
| Year to date | −99.0% | −93.6% |
| 1 year | −99.7% | −94.6% |
| Revenue growth (YoY) | — | −1.6% |
| Gross margin | 29.5% | 26.2% |
| Net margin | −225.1% | −16.9% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 0.1× |
| Net cash | $9.4M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 677.5% | 82.1% |
| Short % of float | 0.8% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).